![Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters](https://pubs.acs.org/cms/10.1021/acs.nanolett.9b02220/asset/images/large/nl-2019-022203_0002.jpeg)
Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters
![Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters](https://pubs.acs.org/cms/10.1021/acs.nanolett.9b02220/asset/images/large/nl-2019-022203_0001.jpeg)
Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces | Nano Letters
![IJMS | Free Full-Text | Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation IJMS | Free Full-Text | Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation](https://www.mdpi.com/ijms/ijms-23-00732/article_deploy/html/images/ijms-23-00732-g001.png)
IJMS | Free Full-Text | Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation
![Figure 4 from Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples | Semantic Scholar Figure 4 from Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dd6c2061ffb8e90cbe794a8b3c0e5a76bc94ff7a/7-Figure4-1.png)
Figure 4 from Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples | Semantic Scholar
![Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile](https://i1.rgstatic.net/ii/profile.image/983771813773315-1611560886190_Q512/Anita-Marosan-2.jpg)
Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile
![Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile](https://www.researchgate.net/publication/354073734/figure/fig2/AS:1059960976863237@1629725798849/No-signs-of-autoimmunity-in-Siglec-H-ko-mice-upon-influenza-infection-Mice-were_Q320.jpg)
Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile
![Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile Anita MAROSAN | PhD Student | Master of Science | Universitätsklinikum Erlangen, Erlangen | Department of Immune Modulation | Research profile](https://www.researchgate.net/publication/354073734/figure/fig3/AS:1059960976850956@1629725798892/After-LCMV-clone-13-infection-Siglec-H-ko-mice-show-less-weight-loss-and-no-increased_Q320.jpg)